KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardinal Health (CAH) Capital Expenditures (2016 - 2025)

Cardinal Health's Capital Expenditures history spans 17 years, with the latest figure at $131.0 million for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 32.32% year-over-year to $131.0 million; the TTM value through Dec 2025 reached $597.0 million, up 20.85%, while the annual FY2025 figure was $547.0 million, 7.05% up from the prior year.
  • Capital Expenditures for Q4 2025 was $131.0 million at Cardinal Health, up from $108.0 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $232.0 million in Q2 2025 and bottomed at $67.0 million in Q3 2021.
  • The 5-year median for Capital Expenditures is $108.5 million (2023), against an average of $119.6 million.
  • The largest annual shift saw Capital Expenditures fell 22.92% in 2021 before it skyrocketed 34.12% in 2023.
  • A 5-year view of Capital Expenditures shows it stood at $74.0 million in 2021, then increased by 14.86% to $85.0 million in 2022, then soared by 34.12% to $114.0 million in 2023, then dropped by 13.16% to $99.0 million in 2024, then soared by 32.32% to $131.0 million in 2025.
  • Per Business Quant, the three most recent readings for CAH's Capital Expenditures are $131.0 million (Q4 2025), $108.0 million (Q3 2025), and $232.0 million (Q2 2025).